PARIS – Health status should be evaluated when determining how best to treat an older man with prostate cancer, attendees at an international congre... More »
HYATTSVILLE, MD. – The majority of a Food and Drug Administration advisory panel voted against approval of an orally disintegrating sublingual table... More »
Among older men with high-risk prostate cancer, receiving androgen-deprivation therapy in combination with radiotherapy reduced cause-specific and all... More »
SAN ANTONIO – Male breast cancers share some important characteristics with female breast cancers: The tumors found in males are usually hormone receptor positive and of luminal A subtype, and...
Mounting evidence suggests that there may be an increased risk of prostate cancer among men with the highest levels of vitamin D.
At a public conference on vitamin D sponsored by the National...
Dr. Benjamin Davies has responded to advertising claims that recently ran in the Sunday New York Times Magazine and the New Yorker with an article in Forbes entitled “Prostate Cancer Advertising:...
Adding abiraterone to standard neoadjuvant therapy using luteinizing hormone-releasing hormone agonists induces markedly more effective androgen suppression within the prostate tissue in men who have...
SAN FRANCISCO – Use of a shorter, more convenient course of radiation therapy for prostate cancer or a technique that spares blood vessels critical for sexual function yields good long-term quality...
Pediatricians should be aware of the most recent updates in contraception and considerations for special populations so they can appropriately counsel their adolescent patients, according to the new...
Men with a combination of frontal and moderate vertex baldness at age 45 were at a significantly increased risk of having aggressive prostate cancer in a large prospective cohort study, according to...